Enanta (ENTA) traded up 3.09 % during a 24 hours period ending at 05:27 AM Central Europe on Wednesday 28th. One Enanta stock can currently be bought for about USD 12.18 on popular exchanges. Current supply of Enanta stocks is 29.1 mn. Enanta has a current market capitalization of USD 341.4 mn and approximately USD 5.3 mn worth of Enanta was traded on exchanges in the last 24 hours. Since last month end, Enanta has traded -4.88 % down. Simple moving average of last 200 days is at USD 13.23. The highest price of past 52 weeks was recorded at USD 17.15 on 12/29/2025. 52 weeks low was at USD 10.22 on 11/07/2025.
Here is how related stocks have performed in the past 24 hours:
Chemung (CHMG) traded up 1.86 % and now trades at USD 85.21. Current market capitalisation for Chemung is USD 409.2 mn. Chemung has a current price to earnings ratio of 12.21.
Shoulder Innovations (SI) traded down -1.42 % and now trades at USD 19.34. Shoulder Innovations has a market capitalisation of USD 409.3 mn.
Altimmune (ALT) traded down -3.3 % and now trades at USD 2.04. Current market capitalisation for Altimmune is USD 408.5 mn.
Assembly Biosciences (ASMB) traded down -0.86 % and now trades at USD 20.3. Assembly Biosciences has a market capitalisation of USD 402.2 mn.
Ars (SPRY) traded down -2.73 % and now trades at USD 3.73. Ars has a market capitalisation of USD 403.8 mn.
About Enanta
Enanta Pharmaceuticals, Inc. is a biotechnology company that specializes in conducting research, development, and creation of small molecule drugs for viral infections and liver diseases. These drugs are intended to serve patients and customers residing within the United States. The company’s website can be accessed under www.enanta.com , and it is traded on the Nasdaq stock exchange. The Initial Public Offering (IPO) of Enanta Pharmaceuticals took place on March 21, 2013.